Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Mishra Dhatu Nigam - Lot many levers left to capture - ICICI Securities

Posted On: 2020-09-13 22:24:35


Space continues to be major driver for Mishra Dhatu Nigam (Midhani) orderbook and execution. Space contributed ~80% of FY20 end orderbook, ~ 55% of FY20 execution and 64% of order inflows. This is the major reason for increase in Gross Margins that we have witnessed in FY20. Higher value addition, import substitution by ISRO, limited/no domestic competition have helped realisation and EBITDA profile to such peaks (Table 1). However, the process doesn't seem to have achieved full economies of scale with only 39% asset turn for FY20 and conversion costs increasingly significantly. Ex of grants for customer financed projects, Midhani continues to be largely debt free - net debt of Rs 227mn in FY20. Customer advances (mainly ISRO) has increased ~ 60% YoY to Rs 5.3bn in FY20 - the benefit of having a well-funded government department like ISRO as a customer. Maintain BUY.

- Volumes declined 8% YoY; realisation and EBITDA/te increase signifies higher value addition and the benefits of being the sole supplier of critical material to ISRO. Realisation/te increased 9%, while EBITDA/te increased 17% YoY in FY20. The nature of the business reflects in realisation/EBITDA profile i.e technology absorption from a customer (ISRO) determined for import substitution, limited/no domestic competition, favourable raw material trajectory ( Nickel expectantly to be in surplus given substantial investment in Nickel Pig iron in Indonesia).

- Key capex projects - focus still on increasing capacity/debottlenecking. Despite production declining 8% YoY (indicative of higher and higher value addition) and asset turn declining from 51% to 39% YoY, focus still remains on debottlenecking/adding capacity. Also, significantly higher conversion costs also signify that perhaps higher capex is required to reduce operating costs/sustain value addition. The key capex projects completed, undertaken or under commissioning include

i) A Vacuum Induction Melting Furnace is being added in Melt area, for capacity enhancement and for accommodating future demands of special steels and super alloys. Order for equipment has been placed and commissioning is expected in Q4FY21.

ii) High capacity casting facility for Titanium alloys is being set up. Procurement action has been initiated and the equipment delivery has commenced. Commissioning is expected in Q3FY21.

iii) Wide plate mill equipment erection is under progress and testing and commissioning will commence thereafter. This is a customer funded project.

iv) Development of Armour unit at Rohtak (Haryana). Major construction activities of Phase-I has been completed. Procurement action has been taken for major line equipments. Procurement of electrical and utilities are under progress.

- Nalco Midhani JV. Named as Utkarsha Aluminum Dhatu Nigam - the JV company has been allotted around 110 acre of land in Andhra Pradesh and it yet to commence the commercial operation. The manufacturing plant involves an estimated capital expenditure of Rs45bn. MIDHANI and NALCO have subscribed 20mn equity shares of Rs. 10/- each of JV Company (by way of initial share capital and by way of rights issue; investment of Rs 200mn).

- Other observations. GST/customs duty receivable has gone up significantly to Rs1769mn from Rs 864mn YoY. We also witness a reduction in R&D expenses from Rs 146mn to Rs 33mn YoY. Midhani remains one of the very few defence/space companies in India who is not paying any liquidated damages but earning in liquidated damages from suppliers.

Shares of Mishra Dhatu Nigam Ltd was last trading in BSE at Rs.201.05 as compared to the previous close of Rs. 204.3. The total number of shares traded during the day was 26533 in over 737 trades.

The stock hit an intraday high of Rs. 205.05 and intraday low of 198. The net turnover during the day was Rs. 5380410.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities

Solar Industries - Overseas and defence key to profitability - ICICI Securities

Federal Bank - Strengthening liability muscle; fees & charges revised upwards - ICICI Securities

HCL Technologies Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd

CAMS - IPO Note - YES SECURITIES

I-direct Instinct - Intellect Design Arena

P&G Health - Company Update - ICICI Securities

Relaxo Footwears - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Bata India - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Listing of Happiest Minds Technologies - Angel Broking

Dr. Reddy's Lab - Sep 17, 2020 - Angel Broking

VA Tech Wabag - Uphill task ahead; dilution at discount valuation - ICICI Securities

Polymer price tracker - PVC price hikes continue unabated - ICICI Securities

Brigade Enterprises - Resilience amid turbulence - ICICI Securities

Apollo Hospitals Enterprises - Recovering well from COVID-19 impact - ICICI Securities

NTPC - Sustainability targets encouraging - ICICI Securities

Gladiator Stocks - Oberoi Realty - ICICI Securities

Gladiator Stocks - Automotive Axles - ICICI Securities

Quant Pick - IDFC First Bank - ICICI Securities

Company Update - Jammu & Kashmir Bank - ICICI Securities

India Aviation Data - August 2020 - Angel Broking

Shree Cement - Higher volumes to offset lower prices - ICICI Securities

Apollo Hospitals - Q1FY21 Result Update - ICICI Securities

Refining & marketing - Oil price fall boosted GRMs, to push marketing margins up - ICICI Securities

Mr. Deepak Jasani, Head of Retail Research views on FICCI National Executive Committee Meeting with Reserve Bank of India Governor Shaktikanta Das

India trade deficit for August 2020 - Angel Broking

Chemcon Chemicals IPO - Mr. Keshav Lahoti - Associate Equity Analyst, Angel Broking Ltd

CAMS IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

August 2020 Trade Data - Acuité Ratings & Research

Wim Plast - Q1FY21 Result Update - ICICI Securities

Company Update - Mishra Dhatu Nigam - ICICI Securities

Stock Tales - Laurus Labs - ICICI Securities

Stock Tales - Granules India - ICICI Securities

Stock of the day - Chalet Hotel - Target INR 200 - Angel Broking

Upgrade to ADD on Dr. Reddy's Labs - Improved visibility in the US business - HDFC Securities

Monetary Policy post CPI inflation numbers for August 2020 - Angel Broking

HUDCO - Q1FY21 Result Update - Angel Broking

Update on Steriscience pharma - Angel Broking

Covid-19 vaccine development by AstraZeneca - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019